We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > nitrosamines

News List

CHMP recommends five medicines for approval in latest meeting europeanpharmaceuticalreview
November 17, 2020
The European Medicines Agency committee reports its November findings, including five drugs recommended for marketing authorisation.
EMA issues opinion on nitrosamines in medicines europeanpharmaceuticalreview
July 14, 2020
The agency’s opinion will require companies to take measures to reduce nitrosamine impurities in medicines and carry out and action the results of risk assessments.
EMA finalises opinion on presence of nitrosamines in medicines expresspharma
July 13, 2020
Companies will be required to have appropriate control strategies to prevent or limit the presence of these impurities and, where necessary, improve their manufacturing processes.
EMA to provide guidance on avoiding nitrosamines in medicines europeanpharmaceuticalreview
September 18, 2019
The EMA has announced it is drafting guidance on how to avoid the presence of nitrosamines, a probable carcinogenic ingredient, in drugs.